Did you know that Tiefenbacher Group is in the final phase of constructing a new, state-of-the-art laboratory and production site for highly potent drugs against cancer and other diseases?
The new complex is located at Tiefenbacher Laboratories in Hyderabad, India. It covers a total area of approximately 4,000 m². It provides laboratories with the latest equipment and full safety measures. Additional there is a production block with special technologies in a GMP-compliant environment. Tiefenbacher Pharmaceuticals (FDF business unit of Tiefenbacher Group) has already more than 20 leading highly potent drugs in its launch pipeline which are planned to be developed and produced in the new facilities.
These investments in infrastructure and technology reflect the company’s commitment to continuously improving healthcare. Furthermore it goes along with our goal of making high-quality medicines more affordable, more available and better than before. The new site is expected to be fully operational still this year.
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
